Clinical Trial Update: Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update describes a head-to-head comparison of desmopressin and fesoterodine for nocturia in women aged 65 and older, spanning Phase 2 and Phase 3…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin (DDAVP) (Desmopressin)
• Fesoterodine (Toviaz) (fesoterodine)

Snippet

Sponsor: Mount Sinai Hospital, Canada | Conditions: Nocturia | Phase 2, Phase 3 | Status: TERMINATED